Mark Durham
2010
Compensation breakdown
Non-Equity Incentive Plan | $295,000 |
---|---|
Option Awards | $704,250 |
Salary | $376,337 |
Stock Awards | $628,038 |
Other | $18,510 |
Total | $2,022,135 |
Durham received $704.3K in option awards, accounting for 35% of the total pay in 2010.
Durham also received $295K in non-equity incentive plan, $376.3K in salary, $628K in stock awards and $18.5K in other compensation.
Rankings
In 2010, Mark Durham's compensation ranked 3,029th out of 10,439 executives tracked by ExecPay. In other words, Durham earned more than 71.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,029 out of 10,439 | 71st |
Division Manufacturing | 1,056 out of 3,838 | 73rd |
Major group Chemicals And Allied Products | 204 out of 921 | 78th |
Industry group Drugs | 106 out of 680 | 84th |
Industry Pharmaceutical Preparations | 84 out of 481 | 83rd |
Durham's colleagues
We found eight more compensation records of executives who worked with Mark Durham at Valeant Pharmaceuticals International in 2010.
2010
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2010
Gilbert Godin
Valeant Pharmaceuticals International
Chief Operating Officer
2010
Margaret Mulligan
Valeant Pharmaceuticals International
Chief Financial Officer
2010
Gregory Gubitz
Valeant Pharmaceuticals International
General Counsel
2010
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2010
Rajiv De Silva
Valeant Pharmaceuticals International
Chief Operating Officer
2010
Robert Chai-Onn
Valeant Pharmaceuticals International
General Counsel
2010
Philip Loberg
Valeant Pharmaceuticals International